News
Antimicrobial resistance is a global issue, making the search for a new generation of antibiotics imperative. Scientists ...
Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new ...
They were founded before 1900, endured two World Wars, two bankruptcies, the bailout-era crisis, and remained standing. Among ...
Directors intend to take up entitlements in part or in full in the Entitlement Offer ...
Q3 2025 Earnings Call Transcript April 8, 2025 Tilray Brands, Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS ...
As another 4/20 approaches, licensed cannabis bars, lounges, tour services and day spas are finally a reality in the Mile High City.
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
6d
Stockhead on MSNRecce raising up to $15.8m for Phase III trialsTargeting first revenue in 2026, Recce will use new funds of up to $15.8m to support a Phase III registrational topical clinical trial for its diabetic foot infection (DFI) treatment in Indonesia.
The first 24 hours of a piglet’s life are critical—get it right, and you’re on your way to a healthy, thriving market hog. Get it wrong, and you could be looking at lifelong struggles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results